Mylan Strikes Deal With Pfizer To Sell Generic Celebrex
Mylan Pharmaceuticals Inc. has reached a deal with Pfizer Inc. to allow it to begin selling generic versions of arthritis drug Celebrex by the end of the year, Mylan said in a statement...To view the full article, register now.
Already a subscriber? Click here to view full article